Congenital Dyserythropoietic anemia, type 1, in a Polynesian patient:: Response to interferon α2b

被引：13

作者：

Roda, L

Pasche, J

Fournier, A

Terorotua, V

Wickramasinghe, SN

Tamary, H

Schischmanoff, PO

Tchernia, G

Delaunay, J ^{[1
]}

机构：

[1] Hop Bicetre, Serv Hematol Immunol & Cytogenet, Assistance Publ Hop Paris, Fac Med Paris Sud, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France

[2] INSERM, U 473, F-94275 Le Kremlin Bicetre, France

[3] Ctr Hosp Terr, Med Biol Lab, Papeete, France

[4] Ctr Hosp Terr, Serv Pediat, Papeete, France

[5] Ctr Hosp Terr, Serv Nephrol Hemodialyse, Papeete, France

[6] Serv Sante Publ, Tahiti, France

[7] Univ Oxford, Nuffield Dept Clin Lab Sci, London, England

[8] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England

[9] Schneiders Med Ctr Israel, Petah Tiqwa, Israel

[10] Hop Bicetre, Serv Biochim 1, Assistance Publ Hop Paris, Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2002年 / 24卷 / 06期

关键词：

congenital dyserythropoietic anemia; type; 1; hemoglobin level; interferon alpha 2b; Polynesia;

D O I：

10.1097/00043426-200208000-00020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The authors attempted to assess the utility of interferon alpha2b treatment in a Polynesian girl with a relatively severe form of congenital dyserythropoietic anemia, type 1. The diagnosis was established using routine hematologic and biochemical tests, light and electron microscopy, and electrophoresis of red cell membrane proteins. Response to the treatment was monitored using the blood count and reticulocyte count.

引用

页码：503 / 506

页数：4

共 24 条

[1] ALTERATIONS OF GLOBIN CHAIN SYNTHESIS AND OF RED-CELL MEMBRANE-PROTEINS IN CONGENITAL DYSERYTHROPOIETIC ANEMIA-I AND ANEMIA-II
ALLOISIO, N
JACCOUD, P
DORLEAC, E
MORLE, L
PHILIPPE, N
MARGUERITTE, G
BRYON, PA
DELAUNAY, J
[J]. PEDIATRIC RESEARCH, 1982, 16 (12) : 1016 - 1021
[2] EVIDENCE THAT RED-BLOOD-CELL PROTEIN-P55 MAY PARTICIPATE IN THE SKELETON-MEMBRANE LINKAGE THAT INVOLVES PROTEIN-4.1 AND GLYCOPHORIN-C
ALLOISIO, N
VENEZIA, ND
RANA, A
ANDRABI, K
TEXIER, P
GILSANZ, F
CARTRON, JP
DELAUNAY, J
CHISHTI, AH
[J]. BLOOD, 1993, 82 (04) : 1323 - 1327
[3] CONGENITAL DYSERYTHROPOIETIC ANEMIAS - SPLENECTOMY AS A MODE OF THERAPY
CHOUDHRY, VP
SARAYA, AK
KASTURI, J
RATH, PK
[J]. ACTA HAEMATOLOGICA, 1981, 66 (03) : 195 - 201
[4] The congenital dyserythropoietic anaemias
Delaunay, J
Iolascon, A
[J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (04) : 691 - 705
[5] HEIMPEL H, 1968, HELV MED ACTA, V34, P103
[6] Genetic heterogeneity of congenital dyserythropoietic anemia type I
Hodges, VM
Molloy, GY
Wickramasinghe, SN
[J]. BLOOD, 1999, 94 (03) : 1139 - 1140
[7] Katovich MA, 2000, STUD SYMB INTERACT, V23, P3, DOI 10.1525/si.2000.23.3.309
[8] LAVABREBERTRAND T, 1995, BRIT J HAEMATOL, V89, P929
[9] LAVABREBERTRAND T, 1998, HEMATOLOGIE, V4, P169
[10] ACRAL DYSOSTOSIS DYSERYTHROPOIESIS SYNDROME
LEMERRER, M
GIROT, R
PARENT, P
CORMIERDAIRE, V
MAROTEAUX, P
[J]. EUROPEAN JOURNAL OF PEDIATRICS, 1995, 154 (05) : 384 - 388

← 1 2 3 →